2020
DOI: 10.1186/s40981-020-00379-8
|View full text |Cite
|
Sign up to set email alerts
|

Anesthesia management in a patient with very long-chain acyl-Coenzyme A dehydrogenase deficiency

Abstract: Background In a patient with very long-chain acyl-Coenzyme A dehydrogenase (VLCAD) deficiency, metabolism of fatty acids is impaired and a supply of alternative energy is limited when glucose level is insufficient on starvation. Case presentation A 37-year-old woman with VLCAD deficiency was diagnosed with an ovarian cyst and was scheduled for laparoscopic ovarian cystectomy. Glucose was administered intravenously with the start of fasting. Anesthesia was induced with remifentanil, midazolam, and thiamylal, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Volatile anesthetics could not be used for the majority of the case due to its inhibitory effect on the anterior horn cells of the spinal cord that preclude neuromonitoring. Despite previous conflicting recommendations due to concerns for rhabdomyolysis with volatile anesthetic use in VLCADD patients [ 12 ], recent literature reports and the review by Redshaw and Stewart have demonstrated that inhaled anesthetics are safe to use in VLCADD patients and were safely used at the end of our case as well [ 4 , 5 , 13 , 14 ]. The few existing reports on managing patients with VLCADD recommend strict intraoperative monitoring of glucose and serum CK levels along with continuous glucose infusions to prevent hypoglycemia [ 12 , 14 ].…”
Section: Discussionmentioning
confidence: 87%
See 2 more Smart Citations
“…Volatile anesthetics could not be used for the majority of the case due to its inhibitory effect on the anterior horn cells of the spinal cord that preclude neuromonitoring. Despite previous conflicting recommendations due to concerns for rhabdomyolysis with volatile anesthetic use in VLCADD patients [ 12 ], recent literature reports and the review by Redshaw and Stewart have demonstrated that inhaled anesthetics are safe to use in VLCADD patients and were safely used at the end of our case as well [ 4 , 5 , 13 , 14 ]. The few existing reports on managing patients with VLCADD recommend strict intraoperative monitoring of glucose and serum CK levels along with continuous glucose infusions to prevent hypoglycemia [ 12 , 14 ].…”
Section: Discussionmentioning
confidence: 87%
“…VLCADD is a rare disorder with an estimated incidence of 1 : 30,000–400,000 live births [ 3 ]. Due to deficient or defective VLCAD enzyme, these patients are unable to break down fatty acids to utilize as a secondary energy source when glucose levels are low, and thus are prone to hypoglycemia [ 4 , 5 ]. The clinical severity of symptoms varies greatly among patients: some present with multisystemic disease and organ failure, while others only exhibit mild clinical symptoms with vigorous exercise or illness [ 2 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation